The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evolutionary action score of TP53 analysis in pathologically high-risk HPV-negative head and neck cancer from a phase II clinical trial: NRG Oncology RTOG 0234.
 
Chieko Michikawa
No Relationships to Disclose
 
Pedro A. Torres-Saavedra
No Relationships to Disclose
 
Natalie L. Silver
No Relationships to Disclose
 
Paul M. Harari
No Relationships to Disclose
 
Merrill S. Kies
No Relationships to Disclose
 
David Ira Rosenthal
Stock and Other Ownership Interests - Concordia Pharmaceuticals
Honoraria - Merck Serono
Consulting or Advisory Role - Clinigen Group; Merck Serono
Research Funding - Merck Serono
Travel, Accommodations, Expenses - Merck Serono
 
Quynh-Thu Le
Stock and Other Ownership Interests - Aldea
Consulting or Advisory Role - GRAIL
Travel, Accommodations, Expenses - Genentech
 
Richard C. Jordan
Stock and Other Ownership Interests - Genomic Health
 
Dzifa Yawa Duose
Patents, Royalties, Other Intellectual Property - Rice University
 
Saradhi Mallampati
No Relationships to Disclose
 
Sanchit Trivedi
No Relationships to Disclose
 
Rajyalakshmi Luthra
No Relationships to Disclose
 
Ignacio Ivan Wistuba
Consulting or Advisory Role - AstraZeneca/MedImmune; Asuragen; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Guardant Health; HTG Molecular Diagnostics; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; MSD Oncology; Pfizer; Roche
Research Funding - 4D Molecular Therapeutics (Inst); Adaptimmune (Inst); Amgen (Inst); Bayer (Inst); EMD Serono (Inst); Genentech (Inst); Guardant Health (Inst); HTG Molecular Diagnostics (Inst); Karus Therapeutics (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Novartis (Inst); OncoPlex Diagnostics (Inst); Pfizer (Inst); Silicon Biosytems (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; GlaxoSmithKline; Guardant Health; HTG Molecular Diagnostics; MSD Oncology; Pfizer
 
Olivier Lichtarge
Stock and Other Ownership Interests - xDNA llc
Patents, Royalties, Other Intellectual Property - Baylor College of Medicine
 
Robert Leonard Foote
Patents, Royalties, Other Intellectual Property - Bionix
Travel, Accommodations, Expenses - Hitachi Chemical
 
Upendra Parvathaneni
No Relationships to Disclose
 
David N. Hayes
Leadership - GeneCentric
Stock and Other Ownership Interests - GeneCentric
Consulting or Advisory Role - GeneCentric
Patents, Royalties, Other Intellectual Property - I hold several diagnostic patents or pending patents in the area of solid tumor diagnostics
 
Curtis R. Pickering
Patents, Royalties, Other Intellectual Property - Unknown patent licenser through University of California San Francisco
 
Jeffrey Myers
No Relationships to Disclose